Introduction
Intrauterine growth restriction (IUGR) is a major cause of perinatal morbidity and mortality, affecting approximately 4-7% of pregnancies [1] . The IUGR may result from maternal, fetal, and placental risk factors that inhibit biologically determined growth potential of the fetus [2] .
The primary function of platelets is to achieve hemostasis and prevent hemorrhage together with coagulation factors. In addition, platelets are considered to have a role in the pathophysiology of various diseases including severe infections, systemic inflammatory reaction syndrome, and thrombotic diseases [3, 4] . Platelet indices include plateletcrit (PCT), mean platelet volume (MPV), and platelet distribution width (PDW). These indices have been extensively used as diagnostic and prognostic markers in numerous clinical studies reporting on pre-eclampsia, risk of preterm delivery, gestational diabetes mellitus, abnormal placental invasion, and risk of recurrent miscarriage [5] [6] [7] [8] [9] . Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are inflammatory markers used to predict the diagnosis and severity of pre-eclampsia [5, 10] . To the best of our knowledge, there has been no study in the literature investigating the relationship between these inflammatory parameters (PCT, MPV, PLR, and NLR) and IUGR. Therefore, the aim of this study was to investigate the changes occurring in these parameters in pregnancies complicated with IUGR and the role of these parameters in the prediction of being born small for gestational age (SGA).
Material and methods
This cohort study was conducted in a tertiary hospital between January 2014 and January 2017. The study was approved by the Local Ethics Committee (approval no. 2016/21).
Intrauterine growth restriction (IUGR) was accepted as an estimated fetal weight (EFW) or abdominal circumference (AC) less than the 10 th percentile for gestational age either with abnormal Doppler findings (increased umbilical artery pulsatility index above the 95 th centile [11] , absent/ reverse diastolic flow or increased uterine artery resistance) or with an EFW/AC according to the Hadlock formula [12] less than the 3 rd percentile despite having normal Doppler findings [13] . The SGA infants were accepted as infants with a birth weight less than the 10 th percentile as per the birth weight standards defined for Turkey [14] . Patients with isolated IUGR referred to patients with no concomitant morbidity [15] .
The retrospective study included 200 patients aged 18-45 years and at 24-37 weeks of gestation who were hospitalized and followed up at our maternal-fetal medicine unit due to the diagnosis of IUGR. All the patients were normotensive during the follow-up period and no proteinuria was detected in urine samples. Patients were excluded if their IUGR was caused by fetal chromosomal or congenital abnormalities or a maternal medical disease including hypertension, diabetes mellitus, pre-eclampsia or gestational hypertension, gestational diabetes mellitus, intrahepatic cholestasis of pregnancy, pregnancy thrombocytopenia, maternal systemic infection, and multiple pregnancies. Patients using antiplatelet drugs and low-molecular-weight heparin, and patients detected with anemia on hemogram parameters were also excluded from the study. The control group included 200 gestational-age-matched patients with no chronic diseases and no history of drug use except for anti-anemic drugs who underwent routine antenatal follow-up and delivered appropriate gestational age babies in our clinic over the same period as the patient group. No IUGR was detected in the control group during the follow-up period.
The complete blood count parameters in the IUGR group including platelet count, PCT, MPV, lymphocyte count, NLR, and PLR were evaluated based on the initial parameters assessed at hospital admission. In the control group, these parameters were evaluated based on the routine hemogram parameters assessed during routine antenatal follow-ups.
Statistical analysis
Data were evaluated using SPSS 20.0 version for Windows (SPSS Inc., Chicago, IL, USA). The distributions of the continuous variables were tested using the Kolmogorov-Smirnov test. The variables with normal distributions were compared between groups using the independent samples t-test and were expressed as mean ± SD. The Mann-Whitney U test was used to analyze non-normally distributed variables and was expressed as the median (minimum-maximum or interquartile range).
A ROC curve analysis was performed for statistically significant parameters and the area under the curve (AUC) was calculated. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PLR, NLR and lymphocytes were calculated based on the cut-off point defined on the ROC curve. A p value of < 0.05 was considered significant.
Results
The study included a patient group of 200 women with IUGR and a control group of 200 women without IUGR. Table I presents the demographic and clinical characteristics of each group. Maternal age and gestational week at diagnosis were similar in both groups (p > 0.05). Gravida, parity, gestational week at birth, and birth weight were significantly lower in the IUGR group compared to the control group.
Table II presents the PCT, MPV, lymphocyte count, NLR, and PLR values for both groups. The PCT and MPV values were similar in both groups. Lymphocyte count was significantly higher and PLR and NLR values were significantly lower in the IUGR group compared to the control group. In the ROC curve analysis, the AUC values for NLR, PLR, and lymphocyte count were 0.578, 0.611 and 0.604 and statistically significant (Figure 1 ) (p = 0.005, 0.0001, 0.0001, respectively). The best cut-off value for PLR was 135.8 with a sensitivity of 77.5 and a specificity of 38.7. The best cut-off value for NLR was 4.06 with a sensitivity of 54.5 and a specificity of 57.8. The best cut-off value for lymphocytes was 2.1 with a sensitivity of 42 and a specificity of 76.9 (Table III) .
Discussion
To our knowledge, this is the first study in the literature to investigate the changes of inflammatory parameters in complete blood count in isolated IUGR cases and prediction of SGA newborns. We considered that these parameters could have a role in the prediction of SGA as in pre-eclampsia. However, unlike in pre-eclampsia, we found that the MPV and PCT values were similar in the patient and control groups but the NLR value was significantly lower and the PLR value was lower in the IUGR group compared to the control group. Also, lymphocyte count was significantly higher, but this increase was not clinically important.
Pre-eclampsia and IUGR are two disorders that share a common pathophysiology and are both characterized by placental insufficiency caused by insufficient trophoblastic invasion of the spiral ar- teries in the placental bed [16] . In normal pregnancy, neutrophilia or mild neutrophil activation can be seen. However, in pre-eclampsia, marked neutrophil activation has been shown by both direct and indirect evidence as a result of placental ischemia [17] [18] [19] . Consequently, peripheral blood neutrophils play a key role in the development of endothelial cell dysfunction that characterizes the maternal syndrome of pre-eclampsia [20] . In their study on neutrophil activation, Sabatier et al. demonstrated that polymorphonuclear neutrophil activation was present in isolated IUGR and this activation was not different between IUGR and pre-eclampsia groups. The authors also suggested that neutrophil activation is a result of a local or systemic inflammatory response rather than being a primary marker consisting of pathological properties of these diseases [18] . In contrast, the marked neutrophilia seen in pre-eclampsia has not been reported in any patient with isolated IUGR [16] . Furthermore, in their animal study, Gelber et al. found that the complement activation at the maternal-fetal interface triggers recruitment of neutrophils and, ultimately, abnormal placentation and fetal death. The authors also suggested that the prevention of this initial inflammatory damage caused by neutrophils might have favorable effects on pregnancy outcomes [21] . The NLR has been shown in numerous studies to be a useful marker in the determination of the presence and severity of pre-eclampsia. These studies have also suggested that NLR is often increased in pre-eclamptic patients and can be a useful marker in clinical practice, particularly for prediction of the severity of pre-eclampsia [5, 10] . Although IUGR shares a common pathology with pre-eclampsia, we found that the neutrophil levels did not increase in the patients with isolated IUGR compared to the controls and the NLR value significantly decreased as a result of increasing lymphocyte count. Immunosuppression occurring in normal pregnancy is not observed in women with IUGR. It has been suggested that increased cellular immunity might play a role in the pathogenesis of IUGR [22] . Also, increase in B lymphocytes in women with IUGR might represent an immunological etiology [23] . The increased lymphocyte count in the present study might be related to fetal immunological rejection that is involved in pathogenesis of IUGR. The NLR values of 4.06 or less can predict SGA with 77.5% sensitivity and 38.7% specificity. Lymphocyte levels of 2.1 or more can predict SGA with 42% sensitivity and 76.9% specificity. In addition, we also found that the PLR value was significantly lower in the IUGR group compared to the control group. The PLR values of 135.8 or less can predict SGA newborns with 54.5% sensitivity and 57.8% specificity. We consider that no neutrophil elevation occurs in isolated IUGR since the physiopathological changes occurring in isolated IUGR are limited to the placenta, contrary to the systemic inflammatory response associated with neutrophil activation that occurs in pre-eclampsia. In normal pregnancies, an increase in platelet synthesis and changes in platelet volumes are observed. Increase in the platelet indices including PCT and MPV are biomarkers of platelet activation [24] . In pre-eclampsia, uncontrolled intravascular platelet activation and increased platelet destruction occur in the maternal circulation as a result of endothelial damage [25, 26] . Similarly, in IUGR, endothelial damage and microthrombosis occur as a result of placental vascular dysfunction and vascular obstructions, leading to increased platelet destruction and increased platelet activity [27] [28] [29] . The literature presents controversial findings regarding the count and size of the platelets in IUGR and/or pre-eclamptic patients [21, [30] [31] [32] [33] . Piazze et al. found that the MPV levels assessed in the third trimester were significantly higher in pregnancies complicated with pre-eclampsia compared to normal pregnancies [30] . Similarly, Kanat-Pektaş et al. reported that the MPV values assessed in the first trimester can predict pre-eclampsia with 66.7% sensitivity and 63.8% specificity and can predict IUGR with 82.4% sensitivity and 60.0% specificity at a cutoff point of 10.5 fl [34] . Conversely, Kashanian et al. reported that the MPV values assessed in the first and third trimester in pregnancies complicated with pre-eclampsia are relatively higher, have a lower predictive value, and are not a good predictor of pre-eclampsia [35] . In our study, we found no significant difference in the MPV values between the IUGR and the control group. The PCT refers to the volume occupied by platelets in the blood as a percentage and is calculated according to the formula PCT = platelet count × MPV/10,000 [36] [37] [38] . Karateke et al. [39] reported that the PCT value was significantly lower in pregnancies complicated with severe pre-eclampsia compared to the control group, whereas Kirbas et al. [5] found no difference in the MPV and PCT values assessed in the first trimester between the pre-eclamptic patients and the controls. Similarly, we found no difference in the PCT values between the patient and control groups. Our findings may indicate that platelet activation does not occur in patients with isolated IUGR. Our study was limited since it had a retrospective design. Further studies with a prospective design and larger patient series including IUGR patients with pre-eclampsia and evaluation of hemogram parameters assessed in the first trimester of pregnancy are needed.
Data expressed as mean ± SD, median (interquartile range). P < 0.05 was considered statistically significant. IUGR -intrauterine growth restriction, NLR -neutrophil-to-lymphocyte ratio, PLR -platelet-to-lymphocyte ratio, PCT -plateletcrit, MPV -mean platelet volume.
In conclusion, NLR, PLR, and lymphocyte count appear to be useful markers for the prediction of SGA newborns. However, their low sensitivity and specificity values restrict their use in clinical practice.
